Background-Reactive oxygen species are major determinants of vascular aging. JunD, a member of the activated protein-1 family of transcription factors, is emerging as a major gatekeeper against oxidative stress. However, its contribution to reactive oxygen species homeostasis in the vasculature remains unknown. Methods and Results-Endothelium-dependent vasorelaxation was impaired in young and old JunD −/− mice (6 and 22 months old) compared with age-matched wild-type mice. JunD −/− mice displayed an age-independent decline in endothelial nitric oxide release and endothelial nitric oxide synthase activity and increased mitochondrial superoxide formation and peroxynitrite levels. Furthermore, vascular expression and activity of the free radical scavengers manganese and extracellular superoxide dismutase and aldehyde dehydrogenase 2 were reduced, whereas the NADPH oxidase subunits p47phox, Nox2, and Nox4 were upregulated. These redox changes were associated with premature vascular aging, as shown by reduced telomerase activity, increased β-galactosidase-positive cells, upregulation of the senescence markers p16 INK4a and p53, and mitochondrial disruption. Interestingly, old wild-type mice showed a reduction in JunD expression and transcriptional activity resulting from promoter hypermethylation and binding with tumor suppressor menin, respectively. In contrast, JunD overexpression blunted age-induced endothelial dysfunction. In human endothelial cells, JunD knockdown exerted a similar impairment of the O 2 − /nitric oxide balance that was prevented by concomitant NADPH inhibition. In parallel, JunD expression was reduced in monocytes from old versus young healthy subjects and correlated with mRNA levels of scavenging and oxidant enzymes. Conclusions-JunD provides protection in aging-induced endothelial dysfunction and may represent a novel target to prevent reactive oxygen species-driven vascular aging. (Circulation. 2013;127:1229-1240.)
T he prevalence of cardiovascular disease is markedly age dependent and a major cause of myocardial infarction and death among elderly patients. A key alteration of aging arteries is the development of endothelial dysfunction, which is associated with a reduction in the bioavailability of nitric oxide (NO). [1] [2] [3] The primary mechanism of aging-associated endothelial dysfunction is oxidative stress, a state in which the generation of reactive oxygen species (ROS) exceeds the capacity of cellular antioxidant defense systems. 4 Of note, superoxide anion (O 2 − ) inactivates endothelium-derived NO. [5] [6] [7] From the interaction of O 2 − with NO, the highly reactive peroxynitrite (ONOO − ) is formed. 5 As a consequence, vasodilation and the antithrombotic and antiinflammatory effects mediated by the endothelium are impaired, resulting in vascular damage. 8, 9 Although the accumulation of ROS generation is the most widely accepted cause of vascular aging, 4,10 a thorough understanding of the molecular mechanisms of altered redox signaling in endothelial cells remains elusive.
Clinical Perspective on p 1240
Activator protein-1 (AP-1) is a collection of dimeric complexes made by different members of 3 families of DNA-binding proteins: Jun, Fos, and ATF/CREB. [11] [12] [13] These members assemble to form AP-1 transcription factors with activities that are strongly influenced by their specific components and their cellular environment. 12 JunD, the most recent gene of the Jun family, regulates cell growth and survival and protects against oxidative stress by modulating genes involved in antioxidant defense and ROS production. Along these lines, JunD −/− mice exhibit shortened life span and increased incidence of aggressive cancers. [14] [15] [16] Recent evidence demonstrated an accumulation of ROS in JunD −/− murine embryonic fibroblasts that was reduced by treatment with ascorbate. 17 Gene expression profiling of JunD −/− cells showed downregulation of several free radical scavenging enzymes associated with an increase in the expression of ROS-producing NADPH oxidase. 17 In contrast, overexpression of JunD blunting redox signaling abolished ROS production and apoptosis. 17, 18 In this study, we tested the hypothesis that JunD may be a critical regulator of vascular homeostasis by investigating its role in ROS-driven vascular aging.
Methods
A detailed description of the methods used in this study is provided in the online-only Data Supplement.
Animals
Young (6-month-old) and old (22-month-old) male JunD −/− mice and male wild-type (WT) littermates were obtained from Institut Curie (Paris, France). Control and knockout mice shared an identical genetic background because both mice lines are of the same C57BL6/129Sv background. As a result of male sterility, the JunD-deficient colony was maintained through the breeding of heterozygous animals. 14 Genotyping was performed by polymerase chain reaction (PCR) on tail samples as previously described. 14 Mice were housed in temperature-controlled cages (20°C-22°C), fed ad libitum, and maintained on a 12/12-hour light/dark cycle. All animal experiments were approved by the local institutional animal care committee.
Tissue Harvesting and Organ Chamber Experiments
On the day of the experiment, mice were anesthetized by the intraperitoneal administration of 50 mg/kg sodium pentobarbital and then euthanized. The chest and abdomen were opened with a medial sternotomy. The aorta was cleaned from adhering connective tissue under a dissection microscope and immediately used for organ chamber experiments.
Measurements of Mitochondrial O 2 − , NO, and ONOO − From Mouse Aorta
Superoxide anion was measured in mitochondria isolated from mouse aorta by the use of electron spin resonance (ESR) spectroscopy analysis as previously reported. 19 In situ measurements of NO and ONOO − were carried out with electrochemical nanosensors. 20, 21 
Isolation of Mitochondrial and Cytosolic Fraction
Mitochondria were isolated by centrifugation as previously reported. 19 
Mitochondrial Swelling Assay
Isolated mitochondria (40 µg) from mouse aortas in swelling buffer [250 mmol/L sucrose, 10 mmol/L 3-(n-morpholino)propanesulfonic acid, 5 µmol/L EGTA, 2 mmol/L MgCl 2 , 5 mmol/L KH 2 PO 4 , 5 mmol/L pyruvate, 5 mmol/L malate] were incubated with 150 µmol/L calcium chloride (CaCl 2 ) in a final volume of 200 µL in a 96-well plate for 20 minutes. Absorbance was read every 30 seconds at 520 nm. 22 
Mitochondrial DNA Damage Detection
Assessment of mitochondrial DNA damage was performed by the use of quantitative PCR-based amplification of a large fragment of mitochondrial DNA as previously described. 23 
Western Blotting
Frozen samples of aortas were pulverized and dissolved in lysis buffer (120 mmol/L sodium chloride, 50 mmol/L Tris, 20 mmol/L sodium fluoride, 1 mmol/L benzamidine, 1 mmol/L DTT, 1 mmol/L EDTA, 6 mmol/L EGTA, 15 mmol/L sodium pyrophosphate, 0.8 µg/mL leupeptin, 30 mmol/L p-nitrophenyl phosphate, 0.1 mmol/L phenylmethanesulfonyl fluoride, and 1% NP-40) for immunoblotting.
Detection of Membrane Translocation of the NADPH Subunit P47phox
This method is reported in the online-only Data Supplement.
Manganese and Extracellular Superoxide Dismutase Activity
Manganese superoxide dismutase and extracellular superoxide dismutase activity was measured in isolated mitochondria and aortic lysates, respectively, by use of a commercially available kit (OxiSelect Superoxide Dismutase Activity Assay, Cell Biolabs, Inc).
NADPH and Xanthine Oxidase Activity
Commercially available kits were used to assess NADPH and xanthine oxidase activity in aortic lysates of JunD −/− and WT mice (abcam).
Aldehyde Dehydrogenase 2 Activity
Aldehyde dehydrogenase 2 activity was determined in mitochondria isolated from mouse aorta of JunD −/− and WT mice according to the manufacturer's recommendations (aldehyde dehydrogenase 2 activity assay kit, abcam).
Coimmunoprecipitation
Immunofluorescence
Thoracic aorta segments from all mice were embedded in optimum cutting temperature and stored at −80°C. Slices 5 μm thick were then cut, blocked with 1% BSA for 1 hour, and incubated overnight at 4°C with anti-3 nitrotyrosine (Upstate Biotechnology), CD31 (BD Biosciences), p47phox, Nox2, Nox4, p53, p16 INK4a , and JunD antibodies (Santa Cruz Biotechnology, Nunningen, Switzerland). Fluorescence-labeled secondary antibodies (Alexa Fluor 546 and 488, Molecular Probes) were applied for 1 hour. Slides were successively incubated with DAPI solution (Vector Laboratories) for 10 minutes and analyzed by fluorescence microscopy (Olympus). Quantification of immunofluorescence was performed by counting stained cells on total cells.
In Vivo Knockdown of JunD
In vivo knockdown of JunD was performed by injecting a predesigned siRNA specifically targeting JunD (Santa Cruz Biotechnology), together with a cationic transfection reagent (JetPEI, Polyplus Transfection), as previously reported. 19 
JunD Overexpression in Mice
Old (22 months) male mice were injected intravenously with either 40 µg cloning vector (Origene, PCMV6-Kan/Neo, PCMV6KN) or a predesigned mouse JunD cDNA clone (Origene, MC200652), together with a cationic transfection reagent (JetPEI), according to the manufacturer's instructions.
Telomerase Activity
The catalytic activity of telomerase was assessed by quantitative PCR as described previously. 24
β-Galactosidase Staining
See the online-only Data Supplement for a description of this method.
Cell Culture
Human aortic endothelial cells (passages 5-8) were cultured in EGM-2 containing 2% FCS for 12 hours and then transfected with JunD, p47phox, Nox2, Nox4, and scrambled siRNAs. After 72 hours, cells were harvested for immunoblotting, ESR measurements, and assessment of NADPH activity.
Real-time PCR
All PCR experiments were performed with the SYBR Green JumpStart kit (Sigma Aldrich). A detailed description of this method, including primer sequences, is given in the online-only Data Supplement. O 2 - and NO levels in intact cells were assessed by ESR spectroscopy analysis as previously described. 25 
Measurements of O 2 − and NO by ESR Spectroscopy

siRNA Transfection
Human aortic endothelial cells were transfected at 70% to 80% confluence with the lipofectamine reagent (Invitrogen, Carlsbad, CA) for 4 hours at 37°C in EBM-2. Commercially available human JunD, p47phox, Nox2, and Nox4 siRNAs were purchased from Santa Cruz Biotechnology. A predesigned scrambled siRNA was used as a control (Microsynth, 5ʹ UAC ACA CUC UCG UCU CU dTdT 3ʹ).
Subjects
Twelve young (24±3 years of age) and 14 old (65±6 years of age) male healthy volunteers were enrolled consecutively at the Blood Donation Service of the University Hospital Zürich. All of the subjects were nonsmokers, normotensive, and free of overt cardiovascular disease as determined by health history questionnaire and physical examination. All participants signed an informed consent.
Isolation of Peripheral Blood Monocytes
Peripheral blood mononuclear cells were isolated from buffy coats by density gradient centrifugation over Ficoll-Paque. Blood monocytes were recovered by adherence to 100-mm plastic tissue culture plates (Griener, Frinckenhausen, Germany) in the presence of 10% FCS for 1 hour at 37°C in 5% CO 2 /air. Nonadherent cells were removed from monocyte monolayers by washing with PBS. Isolated monocytes were cultured in RPMI medium supplemented with 10% FBS. Finally, cells were collected for real-time PCR.
Statistical Analysis
All data are presented as mean±SEM. Statistical comparisons were made with the Student t test for unpaired data and 1-way ANOVA followed by the Bonferroni post hoc test when appropriate. Spearman correlation analysis was used to assess the correlation between variables. Values of P<0.05 were considered statistically significant. All analyses were performed with GraphPad Prism Software (version 5.0).
Results
Genetic Deletion of JunD Accelerates Aging-Induced Endothelial Dysfunction
To investigate the role of JunD in vascular aging, we examined endothelium-dependent responses in 6-and 22-month-old JunD −/− and WT mice. Young JunD −/− mice showed an impairment of endothelium-dependent relaxation to acetylcholine (10 −9 -10 −6 mol/L) that was similar to that observed in old WT mice ( Figure 1A ), suggesting premature endothelial aging in animals lacking the AP-1 transcription factor JunD. Moreover, old JunD −/− mice exhibited a more pronounced impairment of vasorelaxation compared with age-matched WT mice ( Figure  1A ). The addition of the free radical scavenger polyethylene glycol-superoxide dismutase (150 U/mL) restored acetylcholine-induced relaxation not only in old WT mice but also in JunD −/− mice regardless of age ( Figure 1B ). Endotheliumindependent relaxation to sodium nitroprusside (10 −10 -10 −5 mol/L) was similar in all groups ( Figure 1C ). These findings indicate a link among JunD deletion, ROS generation, and endothelial dysfunction.
Mitochondrial Derangement and Oxidative Stress in JunD −/− Mice
Superoxide anion (O 2 − ) was measured by ESR spectroscopy in mitochondria isolated from mouse aorta to directly assess the oxidative stress burden in the presence or absence of JunD. Mitochondrial O 2 − levels were elevated in young animals lacking JunD as in old WT littermates ( Figure 2A ). O 2 − production further increased in 22-month-old JunD −/− mice (Figure 2A ). To investigate the impact of JunD deletion on mitochondrial function, mitochondria isolated from mouse aortas were challenged with calcium overload (150 μmol/L CaCl 2 ), and the rate of mitochondrial swelling was determined by light scattering.
A stable absorbance at 520 nm throughout the 20-minute time course was observed in mitochondria from young WT. In contrast, mitochondria from young JunD −/− mice displayed a significant decrease in absorbance after calcium overload ( Figure 2B and Figure I in the online-only Data Supplement). Interestingly, young JunD −/− mice and old WT littermates showed a comparable mitochondrial disruption ( Figure 2B) . A similar pattern of mitochondrial DNA fragmentation and increased caspase 3 activity was observed ( Figure 2C and Figure II in the online-only Data Supplement).
In agreement with increased mitochondrial O 2 − generation, NO release from single aortic endothelial cells was markedly Figure 2D ). Blunted NO availability was associated with an early reduction of both activating endothelial NO synthase (eNOS) Ser-1177 phosphorylation and total protein in JunD −/− mice ( Figure 2E and Figure III in the online-only Data Supplement). Furthermore, ONOO − levels and 3-nitrotyrosine immunostaining were also elevated in young JunD −/− mice to an even higher level than in aged control animals ( Figure 2F and 2G).
Aging Downregulates JunD Expression
In agreement with the effects of JunD deletion on endotheliumdependent relaxation, immunofluorescence analysis of the mouse aorta revealed that JunD expression is confined mostly to the vascular endothelium ( Figure 3A ). To strengthen the link between the AP-1 transcription factor JunD and age-dependent, ROS-mediated endothelial dysfunction, its protein expression was assessed in aortic lysates obtained from young and old WT mice. Interestingly, old mice showed a downregulation of JunD expression compared with young animals ( Figure 3B ). This finding was confirmed by immunofluorescence analysis showing reduced JunD-specific staining ( Figure 3C ). As expected, JunD −/− mice did not show any protein signal ( Figure 3C ).
Then, we investigated whether JunD downregulation was induced at the transcriptional level by epigenetic changes. Quantitative analysis of JunD promoter methylation, an important repressor of gene transcription, showed a significant increase in methylated CpG dinucleotides in old compared with young mice ( Figure 3D ).
Together with blunted expression, we found that JunD transcriptional activity is reduced in aged vessels ( Figure 3E ). The tumor suppressor menin, a critical modulator of JunD activity, coprecipitated with JunD only in the aorta of old mice, leading to blunted JunD phosphorylation ( Figure 3F and Figure 
Restoration of JunD Expression Improves Vascular Function in Old Mice
Because JunD deletion is associated with early endothelial dysfunction, we determined whether restoration of its expression exerts protective effects against age-induced, ROSdependent endothelial dysfunction. In vivo overexpression of JunD was performed by intravenous injection of a predesigned cDNA clone. This approach resulted in a significant overexpression of JunD in the aorta of old mice, whereas injection of cloning vector did not exert any significant effect ( Figure  VI in the online-only Data Supplement). Interestingly, JunD overexpression improved acetylcholine-dependent relaxation compared with vector-treated mice ( Figure 3G ). This finding indicates that JunD is critically involved in age-dependent endothelial dysfunction.
JunD Affects the Balance Between ROS-Scavenging and ROS-Generating Enzymes
The expression and activity of manganese superoxide dismutase, extracellular superoxide dismutase, and aldehyde dehydrogenase 2 were decreased in the aorta of JunD −/− mice compared with age-matched littermates ( Figure 4A -4C). Similar findings were observed for glutathione peroxidase-1 and xanthine oxidase ( Figure VII in the online-only Data Supplement). In contrast, the NADPH oxidase subunits p47phox, Nox2, and Nox4 were already upregulated in young JunD −/− mice and further increased with aging ( Figure 5A -5C and Figure VIII in the online-only Data Supplement). Upregulation of NADPH isoforms was confined mainly to the vascular endothelium as assessed by immunofluorescence ( Figure 5A -5C). These findings were To further investigate the link between JunD and NADPH in the vascular endothelium, selective downregulation of JunD was achieved with siRNA technology. Interestingly, pretreatment with the NADPH inhibitor apocynin blunted impairment of acetylcholine-induced relaxation in the aortic rings of JunD siRNA-treated young and old mice and in old WT animals ( Figure 5E ).
JunD Deletion Accelerates ROS-Induced Vascular Aging
Because JunD deletion is associated with an early burst of oxidative stress, we investigated markers of vascular senescence in age-matched WT and JunD −/− mice. Telomerase activity was blunted in young JunD −/− compared with age-matched WT mouse aorta, and no further impairment was observed on aging. This finding indicated a vascular senescence phenotype in young animals lacking JunD ( Figure 6A ). β-Galactosidase staining further supported the early occurrence of vascular aging in JunD −/− mice ( Figure 6B ). Accordingly, the expression of aging markers such as tumor suppressor p53 and the cyclin-dependent kinase inhibitor p16 INK4a was increased in these mice ( Figure 6C and 6D and Figure XI 
Gene Silencing of JunD in Human Endothelial Cells
To translate the findings observed in JunD −/− mice to the human endothelium, we downregulated JunD in human aortic endothelial cells using siRNA technology. Selective JunD siRNA markedly reduced its expression, whereas scrambled siRNA did not exert any effect ( Figure 7A ). In line with our findings in the mouse, knockdown of JunD elicited a marked Figure 7C and 7D). Moreover, we also confirmed that JunD is required for eNOS expression and activation in human endothelial cells. Indeed, eNOS protein expression and Ser1177-activating phosphorylation were significantly reduced by JunD knockdown ( Figure 7E ).
Age-Dependent Downregulation of JunD in Old Healthy Subjects
To exploit the role of the JunD gene in human vascular aging, we assessed JunD mRNA expression in peripheral monocytes obtained from young and old human subjects free of overt cardiovascular disease and risk factors. Interestingly, JunD protein and gene expression were significantly reduced in old compared with young individuals ( Figure 8A and 8B). Moreover, mRNA levels significantly correlated with gene expression of scavenger manganese superoxide dismutase, extracellular superoxide dismutase ( Figure 8C and 8D), and the NADPH p47phox and Nox2 subunits ( Figure 8E and 8F). These results suggest that downregulation of JunD may represent an important mechanism of increased oxidative stress burden in human aging.
Discussion
JunD is emerging as a major gatekeeper against oxidative stress, 15 but its contribution to ROS homeostasis in the vasculature remains unknown. The present study demonstrates for the first time that genetic deletion of JunD is associated with premature endothelial dysfunction and vascular aging via ROS generation. Several lines of evidence support our conclusions. In contrast to young WT mice, age-matched mice lacking JunD showed an early impairment of endotheliumdependent relaxation that was restored by the ROS-scavenging enzyme polyethylene glycol-superoxide dismutase. A marked increase in mitochondrial O 2 − , paralleled by reduced endothelial NO bioavailability and elevated ONOO − concentrations, was already found in the aorta of young JunD −/− mice. JunD deletion was associated with downregulation of free radical scavengers and increased expression and activity of ROS-generating NADPH oxidase. JunD expression was reduced in old compared with young WT mice, implying that the protective role of this transcription factor is diminished with aging. Interestingly, overexpression of JunD rescued age-induced endothelial dysfunction. Oxidative stress burden in JunD −/− mice led to premature vascular senescence. Last but not least, JunD was downregulated in peripheral monocytes of old healthy subjects and correlated with scavenging and oxidant enzymes, suggesting a potential translation of our findings to the clinical context.
The AP-1 transcription factor JunD modulates different target genes involved in proliferation, growth, and survival. 13, 26, 27 Gerald and colleagues 17 previously reported increased ROS generation in immortalized JunD −/− cells. In contrast, redox signaling involved in tumor angiogenesis was blunted by JunD overexpression. Notably, JunD −/− mice display reduced life span. [14] [15] [16] In the present study, double immunostaining with the endothelial marker CD31 showed that JunD is expressed in the vascular endothelium. Hence, we investigated whether its genetic deletion was associated with a premature oxidative phenotype in the vasculature. availability was blunted in young mice carrying the genetic disruption of JunD. These mice also showed increased DNA fragmentation, swelling of the mitochondria, and caspase 3 activation, markers of apoptosis. The increase in oxidative stress was associated with impaired balance between ROSscavenging and -producing enzymes. Expression and activity of extracellular superoxide dismutase, manganese superoxide dismutase, glutathione peroxidase-1, and xanthine oxidase were significantly reduced in knockout mice, suggesting that JunD is essential for their transcription. In addition, the mitochondrial reductase aldehyde dehydrogenase 2 was almost abolished in young JunD −/− mice compared with agematched littermates. This scavenging enzyme has recently been reported to reduce ischemia/reperfusion injury and to protect against cardiac arrhythmias. [28] [29] [30] We show that JunD deletion affects aldehyde dehydrogenase 2 expression and activity in mouse aorta and that its downregulation may contribute to the abnormal vascular redox state. Our findings are in line with the established role of AP-1 in the activation of several genes encoding a set of detoxifying defensive proteins. Indeed, antioxidant response elements have been identified in the promoters of scavenging enzymes. 31 In contrast, we found that p47phox, Nox2, and Nox4, key subunits of ROS-generating NADPH oxidase, were upregulated in the endothelium of young JunD −/− mice. Notably, the NADPH inhibitor apocynin was able to improve acetylcholine-induced vasorelaxation in the aorta of WT mice with downregulation of JunD induced by siRNA technology. In this regard, we have recently reported that in vivo delivery of siRNA with a cationic reagent targets the vascular endothelium. 19 As observed for JunD −/− mice, silencing of JunD elicited a similar impairment of vasorelaxation. Transient knockdown of the transcription factor allowed us to investigate the effects of gene downregulation more specifically than in the setting of genetic deletion, increasing the physiological relevance of our findings. On the other hand, we also showed that overexpression of JunD blunted endothelial dysfunction in old mice. This latter experiment strongly suggests that modulation of JunD expression plays a role in ROS-mediated vascular dysfunction.
The oxidant-rich milieu observed in young JunD −/− mice was associated with increased NO breakdown, as indicated by elevated ONOO − and protein nitrosylation. However, we also found a decreased expression of eNOS in the aorta of these mice that may contribute to the reduced NO bioavailability. Previous evidence reported that AP-1 is required for eNOS transcription. 32 Interestingly, our findings suggest that AP-1 complexes lacking JunD may not be able to warrant eNOS gene expression. JunD inactivation also blunted eNOS Ser1177 phosphorylation, in line with the notion that ROS suppress enzyme activity. 33 In addition, we showed that oxidative stress in JunD −/− mice was associated with early features of vascular aging, including reduced telomerase activity, increased β-galactosidase staining, and upregulation of the senescence markers p53 and p16 INK4a . Importantly, the extent of vascular senescence observed in young JunD −/− mice was similar to that seen in old WT mice, suggesting that JunD deletion accelerates ROS-driven vascular aging. The importance of premature senescence in this setting is strengthened by the notion that cardiovascular disease, in particular myocardial infarction and stroke, exhibits a strong age dependency. 34 To test JunD role in the human endothelium, JunD siRNAmediated knockdown was performed in human aortic endothelial cells. Silencing of JunD increased NADPH activity and ROS generation, whereas concomitant treatment with apocynin or knockdown of p47phox and Nox2 subunits prevented oxidative stress, confirming that JunD also is a critical modulator of NADPH activity in human endothelial cells. In contrast, gene silencing of Nox4 did not abolish superoxide production, in line with the observation that this subunit is involved in H 2 O 2 generation. 35 Although Nox4 is upregulated in aging 35 and Nox4-derived H 2 O 2 has recently been linked to DNA damage, mitochondrial dysfunction, and senescence phenotypes, [36] [37] [38] other evidence suggests a protective role against vascular ischemic or inflammatory stress. 39, 40 Whether the observed Nox4 upregulation represents a futile compensatory mechanism or contributes to vascular aging in JunD −/− mice remains unclear.
Another important finding of the present study is that JunD expression was downregulated in old compared with young WT animals. Because oxidative stress contributes to aging, we speculate that JunD is crucial in maintaining a redox balance in the vasculature, whereas its deletion is associated with premature ROS-mediated endothelial dysfunction. This conclusion is supported by our previous work showing that normalization of ROS prevents age-related vascular dysfunction. 41 In our effort to elucidate the molecular basis of age-dependent JunD downregulation, we investigated the epigenetic modulation of JunD expression at the transcriptional level. Quantitative analysis of JunD promoter methylation showed a significant hypermethylation of CpG dinucleotides in old compared with young mice. Indeed, DNA methylation is an important repressor of gene transcription in mammals. 42 Besides epigenetic changes, we found that JunD transcriptional activity was reduced in aortas of aged compared with young mice. In this regard, it was recently shown that the tumor suppressor menin binds JunD, leading to inhibition of its activity. 43 Accordingly, in our experimental setting, menin coprecipitates with JunD only in aged, not in young, vessels, and this interaction inhibits JunD-activating phosphorylation. Hence, transcriptional and posttranslational modification may explain the decrease in JunD expression and activity in the vasculature of old mice. Of note, JunD gene expression was downregulated in peripheral monocytes of old healthy subjects and significantly correlated with ROS-scavenging and -generating enzymes. Although we did not confirm the age-dependent decline of endothelial function in our cohort, several studies have reported a strong correlation between age and endothelial dysfunction. [44] [45] [46] 
Conclusions
The present work demonstrates for the first time that JunD is critically involved in age-induced oxidative stress in the endothelium and controls vascular senescence. The strength of our study is the consistent observation of JunD as a protector of endothelial homeostasis in different experimental settings, including knockout mice, human endothelial cells, and healthy individuals. These findings may provide the rationale to pharmacologically modulate JunD expression for the prevention of cardiovascular disease. 
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Supplemental Methods
Tissue Harvesting
On the day of the experiment, mice were anesthetized through the intraperitoneal administration of 50 mg/kg sodium pentobarbital and then euthanized. The chest and abdomen were opened with a medial sternotomy. The entire aorta from the heart to the iliac bifurcation was excised and placed immediately in cold modified Krebs-Ringer bicarbonate solution (pH 7.4, 37°C, 95% O2; 5% CO2) of the following composition (mmol/L): NaCl (118.6), KCl (4.7), CaCl2 (2.5), KH2PO4 (1.2), MgSO4 (1.2), NaHCO3 (25.1), glucose (11.1), and calcium EDTA (0.026). The aorta was cleaned from adhering connective tissue under a dissection microscope and immediately used for organ chamber experiments or snap-frozen in liquid nitrogen and stored at -80°C.
Organ chamber experiments
For endothelial function experiments, aortas were cut into 2-3 mm rings which were connected to an isometric force transducer (Multi-Myograph 610M, Danish Myo Technology, Denmark), suspended in an organ chamber filled with 5 mL Krebs-Ringer bicarbonate solution (37°C, pH 7.4), and bubbled with 95% O 2 , 5% CO 2 . Isometric tension was recorded continuously. After a 30 minute equilibration period, rings were gradually stretched to the optimal point of their length-tension curve as determined by the contraction in response to potassium chloride (100 mmol/L). Concentration-response curves were obtained in a cumulative fashion. 1 Several rings cut from the same artery were studied in parallel. Responses to acetylcholine (Ach, 10 -9 to 10 -6 mol/L, Sigma Aldrich) in the presence or the absence of polyethylene glycol-superoxide dismutase (PEG-SOD, 150 U/mL, Sigma Aldrich) and apocynin (100 µM, Sigma Aldrich) were recorded during submaximal contraction to norepinephrine (NE, 10 -6 mol/L). PEG-SOD and apocynin were added to the organ chamber 30 and 60 minutes before the assessment of endothelium-dependent relaxation to Ach, respectively. The nitric oxide (NO) donor sodium nitroprusside (SNP, 10 -10 to 10 -5 mol/L, Sigma Aldrich) was added to test endothelium-independent relaxation. Relaxations were expressed as percentages of precontraction to norepinephrine. 
Measurements of mitochondrial O 2 by ESR spectroscopy
Measurements of endothelial NO and ONOOfrom mouse aorta
In situ measurements of NO and ONOOwere carried out with three electrochemical nanosensors combined into one working unit with a total diameter of 2.0 -2.5 µm. Their design was based on previously developed and well-characterized chemically modified carbon-fiber technology. 2, 3 Amperometry was performed with a computer-based Gamry VFP600 multichannel potentiostat. A current at the peak potential characteristic for NO injected with a nanoinjector that was also positioned by a computer controlledmicromanipulator.
Isolation of mitochondrial and cytosolic fraction
Thoracic aortas were suspended in the mitochondrial buffer containing 10mM MOPS (pH 7.2), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 10 µg/mL leupeptin, 10 µg/mL aprotinin, and 0.25 M sucrose, and gently homogenized with a Dounce homogenizer (30 strokes).
The homogenate was centrifuged at 750g for 10 minutes at 4°C to remove nuclei and unbroken cells, and the supernatant was centrifuged at 10,000g for 15 minutes. The resultant mitochondrial pellet was resuspended in 40 µL of standard lysis buffer (see Western blot for details) while the supernatant was collected as the cytosolic fraction.
Mitochondrial DNA damage detection
Briefly, each 30 ng of total DNA was used in two PCR reactions, one amplifying a short 117-bp product of mtDNA and the other amplifying a long fragment of 10-kb product of mtDNA. The amount of PCR products from the 10-kb amplification reflects the quality of the template mtDNA, whereas the 117-bp amplification serves as an internal control for template concentration. 4 Primer sequences are shown in Supplemental Table 1. PCR   reaction was run with the following conditions: 10-kb PCR, denaturation at 94°C for 15 seconds, annealing, and extension at 68°C for 12 minutes for 20 amplifying cycles, followed by a final 10 minutes extension;117-bp PCR, 94°C for 30 seconds, 60°C for 45 seconds, 72°C for 45 seconds for 20 cycles, and followed by final extension at 72°C for 10 minutes. mtDNA integrity was determined by calculating the ratios of amount of 10 kb products to that of 117-bp products.
Western blotting
Frozen samples of aorta and HAECs were lysed for immunoblotting (120 mmol/L sodium 
Detection of membrane translocation of NADPH subunit p47phox
Segments of thoracic aortas were homogenized in a lysis buffer [50 mmol/L HEPES (pH 7.4), 50 mmol/L NaCl, 1 mmol/L MgCl 2 , 2 mmol/L EDTA, 1 mmol/L PMSF, 10 mg/ml leupeptin, 1 mmol/L NaVO 4 , and 0.1% Triton X-100] for 5 minutes on ice. Aortic lysates were centrifuged at 15 000 rpm at 4°C for 15 minutes. After the supernatant had been collected as the cytosol fraction, the pellet was resuspended in 1% Triton X-100 in the lysis buffer and centrifuged at 15 000 rpm and 4°C for 15 minutes. The supernatant was then collected as the membrane fraction. Equal amounts (25 μg) of protein from each fraction were subjected to SDS-polyacrylamide gel electrophoresis followed by immunoblotting with anti-p47phox antibody (Santa Cruz Biotechnology, Nunningen, Switzerland).
Co-immunoprecipitation
Segments of mouse aorta were lysed in ice-cold lysis buffer containing 50 mmol/L Tris-HCl, pH 7.4, 100 mmol/L NaF, 15 mmol/L Na4P2O7, 1 mmol/L Na3VO4, 1% Triton X-100, and 1 mmol/L phenylmethylsulfonyl fluoride. Lysates were centrifuged at 10,000 g to remove insoluble material. For immunoprecipitation, precleared lysates were incubated with anti-menin1 antibody overnight at 4°C. Lysates were precleared by incubation with 50 μL of protein A/G-agarose for 2 h at 4°C with rocking. Agarose beads were pelleted by centrifugation at 1000 g. Immunoprecipitated proteins were eluted from the beads by boiling for 5 min in SDS sample buffer and immunoblotted with anti-JunD antibody (1:1000 dilution). Bound antibody was visualized using an enhanced chemiluminescence system (Millipore, Billerica, USA) after incubation of the blot with peroxidase-conjugated secondary antibody for 1 h. 
JunD promoter methylation in mouse aorta
Nuclear extracts and JunD binding activity
Nuclear protein was obtained by using a nuclear extraction kit (Active Motif, Rixensart, Belgium). Aorta segments were lysed in hypotonic buffer for 15 min before centrifugation, isolated nuclei were resuspended in a hypertonic buffer, and nuclear protein was extracted by incubation on a rotator for 30 min. Nuclear and cytosolic fractions were collected after centrifugation. The DNA binding reaction was carried out with 5 μg of nuclear protein in a 96-well plate coated with consensus sequences for JunD for 1 h at room temperature.
After washing, JunD antibody (Active Motif) was added and incubated for 1 h, followed by incubation with a horseradish peroxidase-conjugated secondary antibody. Finally, JunD DNA binding was assessed spectrophotometrically at 450 nm.
In vivo knockdown of JunD
In vivo knockdown of JunD was performed by injecting a predesigned siRNA specifically targeting JunD (Santa Cruz, USA). A scrambled-siRNA was used as a negative control I.v. injections were repeated every other day for 1 week and mice harvested for organ chamber experiments, as described in the methods section. Time course studies showed that JunD overexpression was already evident after 24 hours and injections were repeated to warrant a stable overexpression before ex-vivo assessment of endothelial function.
Telomerase activity
The catalytic activity of telomerase was assessed by quantitative PCR, as described previously. 6 
Beta-galactosidase staining
Senescence-associated β-galactosidase (SA-β-gal) activity is detectable using the artificial The amplification program consisted of 1 cycle at 95 °C for 10 min, followed by 40 cycles with a denaturing phase at 95 °C for 30 s, an annealing phase at 56 °C for 30 s, and an elongation phase at 72 °C for 30 s. A melting curve analysis was performed after amplification to verify the accuracy of the amplicon, and PCR products were analyzed on an ethidium bromide stained 1% agarose gel. Data were normalised to results obtained with primers specific for human TBP and mouse GAPDH. 
Measurement of O 2 and NO in HAECs
